Long-Term Survival in Patients with Cancers
Rokia Sakr(Menoufia University), Mohamed A. Gouda(The University of Texas MD Anderson Cancer Center), Abdelrahman A Nasr(Menoufia University), Eman I Zineldin(Menoufia University)
Cited by 15
Related Papers
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)
|Annals of Oncology|2023|103
Precision oncology for BRAF-mutant cancers with BRAF and MEK inhibitors: from melanoma to tissue-agnostic therapy
|ESMO Open|2023|101
Expanding the Benefit: Dabrafenib/Trametinib as Tissue-Agnostic Therapy for <i>BRAF</i> V600E–Positive Adult and Pediatric Solid Tumors
|American Society of Clinical Oncology Educational Book|2023|92
ALK fusions in the pan-cancer setting: another tumor-agnostic target?
|npj Precision Oncology|2023|89
The evolving landscape of tissue‐agnostic therapies in precision oncology
|CA A Cancer Journal for Clinicians|2024|68